43OUnravelling the context specificity of signalling in KRAS mutant cancers: Implications for design of clinical trials. (5th March 2018) - Banerji, U; Stewart, A; Coker, E A; Minchom, A; Pölsterl, S; Georgiou, A; Al-Lazikani, B